Sicagen India

Who are the top shareholders of the Sicagen India?

The top shareholders of Sicagen India include Ranford Investments Ltd. with 18.7%, followed by individual investors at 28.37%, and Mercantile Ventures Limited at 2.5%. There is also one Foreign Institutional Investor holding 2.42%, while mutual funds have minimal involvement.

The top shareholders of Sicagen India include several key players. The majority shareholders are the promoters, with no pledged promoter holdings reported. The promoter with the highest holding is Ranford Investments Ltd., which holds 18.7% of the shares. <BR><BR>In terms of institutional investors, there is one Foreign Institutional Investor (FII) that holds 2.42% of the company. Additionally, mutual funds have a minimal presence, with three schemes holding 0.0%. <BR><BR>Among public shareholders, Mercantile Ventures Limited is the largest, holding 2.5%. Individual investors collectively hold 28.37% of the shares.

What does Sicagen India do?

Sicagen India Ltd is a micro-cap company specializing in trading and marketing services for construction-related infrastructure. As of March 2025, it reported net sales of ₹252 Cr and a net profit of ₹4 Cr.

Overview:<BR>Sicagen India Ltd is a leading provider of trading and marketing services for construction-related industrial and retail infrastructure, operating in the Trading & Distributors industry within the Micro Cap market-cap bracket.<BR><BR>History:<BR>Incorporated on June 11, 2004, Sicagen India Ltd has maintained its status as a key player in its sector. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 252 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 4 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap: Rs 269 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 17.00<BR>- Industry P/E: 30<BR>- Dividend Yield: 0.88%<BR>- Debt Equity: 0.16<BR>- Return on Equity: 3.20%<BR>- Price to Book: 0.56<BR><BR>Contact Details:<BR>Address: 4th Floor SPIC House, No 88 Mount Road Guindy Chennai Tamil Nadu : 600032<BR>Tel: 91-044-4075 4075<BR>Email: secl@sicagen.com<BR>Website: http://www.sicagen.com

Who are in the management team of Sicagen India?

As of March 2022, the management team of Sicagen India includes Ashwin C Muthiah (Chairman), along with several independent directors and other key members, such as B Narendran, Sashikala Srikanth, and Ankita Jain (Company Secretary). Each member contributes to the company's governance and strategic direction.

As of March 2022, the management team of Sicagen India includes the following individuals:<BR><BR>1. B Narendran - Independent Director<BR>2. Ashwin C Muthiah - Chairman (Non-Executive)<BR>3. Sashikala Srikanth - Independent Director<BR>4. Rita Chandrasekar - Independent Director<BR>5. S Radhakrishnan - Independent Director<BR>6. R Chandrasekar - Director<BR>7. M Rajamani - Independent Director<BR>8. S R Ramakrishnan - Director<BR>9. Varma Nandakumar - Additional Director<BR>10. Ankita Jain - Company Secretary & Compliance Officer<BR><BR>Each member plays a vital role in the governance and strategic direction of the company.

Has Sicagen India declared dividend?

Yes, Sicagen India Ltd has declared a 6% dividend, amounting to 0.6 per share, with an ex-date of September 12, 2024. The company has shown varying total returns over different periods, with significant long-term price growth.

Sicagen India Ltd has declared a 6% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 6%<BR>- Amount per share: 0.6<BR>- Ex-date: 12 Sep 2024<BR><BR>Dividend Yield: 0.88%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, Sicagen India experienced a price return of -25.03% with no dividend return, resulting in a total return of -25.03%.<BR><BR>Over the past year, the company had a price return of 14.83% and a dividend return of 1.02%, leading to a total return of 15.85%.<BR><BR>In the 2-year period, the price return was 44.4% with a dividend return of 2.72%, culminating in a total return of 47.12%.<BR><BR>For the 3-year period, Sicagen India saw a price return of 157.58% and a dividend return of 5.65%, which resulted in a total return of 163.23%.<BR><BR>In the last 4 years, the company achieved a price return of 195.65% along with a dividend return of 9.05%, leading to a total return of 204.7%.<BR><BR>Over the past 5 years, the price return was 352.13% with a dividend return of 18.91%, resulting in a total return of 371.04%.<BR><BR>Overall, Sicagen India has declared a dividend and demonstrated varying total returns across different periods, with significant growth in price returns over the longer term, indicating a positive trend in shareholder value.

Who are the peers of the Sicagen India?

Sicagen India's peers include Redington, MMTC, MSTC, Ravindra Energy, and others, with varying management risks and growth rates. Balgopal Commer. leads in 1-year returns at 225.31%, while Sicagen India has a return of 17.70%.

Peers: The peers of Sicagen India are Redington, MMTC, MSTC, Ravindra Energy, Stratmont Indus., Parshva Enterpr., Balgopal Commer., Uma Exports, and Confidence Fut.<BR><BR>Quality Snapshot: Excellent management risk is observed at Redington, while Average management risk is found at MMTC, MSTC, Balgopal Commer., and the rest. Good management risk is noted at Stratmont Indus., while Below Average management risk is present at Ravindra Energy, Parshva Enterpr., Uma Exports, and Confidence Fut. Growth is Excellent at Redington and Confidence Fut., Good at Sicagen India and Stratmont Indus., and Below Average at MMTC, MSTC, Ravindra Energy, Parshva Enterpr., Uma Exports, and the rest. Capital Structure is Excellent at MSTC, Good at Redington, Parshva Enterpr., and Balgopal Commer., and Below Average at Sicagen India, Ravindra Energy, Stratmont Indus., Uma Exports, and Confidence Fut.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Balgopal Commer. at 225.31%, while the lowest is Confidence Fut. at -26.27%. Sicagen India’s 1-year return of 17.70% is higher than Confidence Fut. but lower than Balgopal Commer. Additionally, peers with negative six-month returns include MSTC, Stratmont Indus., and Confidence Fut.

Is Sicagen India overvalued or undervalued?

As of October 24, 2024, Sicagen India is considered very attractive with a PE ratio of 17.29, a Price to Book Value of 0.55, and an EV to EBITDA of 9.79, significantly outperforming its peers and the Sensex, indicating it is undervalued in the market.

As of 24 October 2024, Sicagen India has moved from an attractive to a very attractive valuation grade. The company is currently undervalued, with a PE ratio of 17.29, a Price to Book Value of 0.55, and an EV to EBITDA of 9.79. In comparison to its peers, Sicagen's PEG ratio stands at a notably low 0.37, while MMTC, a peer, has a significantly high PE ratio of 119.39, indicating that Sicagen is positioned favorably within its industry.<BR><BR>The company's recent performance has also been noteworthy, with a one-month stock return of 24.97%, significantly outperforming the Sensex's 3.88% return over the same period. This performance, combined with its attractive valuation metrics, reinforces the conclusion that Sicagen India is undervalued relative to its peers and the broader market.

What is the technical trend for Sicagen India?

As of May 12, 2025, Sicagen India shows a mildly bearish trend overall, influenced by daily moving averages and mixed signals from MACD and Bollinger Bands, despite some mildly bullish indicators on the weekly chart.

As of 12 May 2025, the technical trend for Sicagen India has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bearish on the monthly. The daily moving averages are mildly bearish, suggesting short-term weakness. The KST is mildly bullish on the weekly but mildly bearish on the monthly, and Dow Theory supports a mildly bullish outlook on both time frames. Overall, the current technical stance is mildly bearish, driven primarily by the daily moving averages and the mixed signals from the MACD and Bollinger Bands.

How big is Sicagen India?

As of 24th July, Sicagen India Ltd has a market capitalization of 281.00 Cr, with recent net sales of 891.88 Cr and a net profit of 17.11 Cr. The balance sheet for March 2024 shows shareholder's funds of 459.75 Cr and total assets of 698.62 Cr.

As of 24th July, Sicagen India Ltd has a market capitalization of 281.00 Cr, classifying it as a Micro Cap company.<BR><BR>In the latest four quarters, Sicagen India reported Net Sales of 891.88 Cr and a Net Profit of 17.11 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 459.75 Cr and Total Assets of 698.62 Cr.

How has been the historical performance of Sicagen India?

Sicagen India's historical performance shows fluctuating net sales and profits, peaking at 895.30 Cr in March 2023 before declining slightly to 891.88 Cr in March 2025. Despite this, operating profit and profit before tax improved, indicating enhanced operational efficiency and a stable financial position.

Answer:<BR>The historical performance of Sicagen India shows a fluctuating trend in net sales and profits over the years, with a notable increase in recent periods.<BR><BR>Breakdown:<BR>Sicagen India's net sales peaked at 895.30 Cr in March 2023 but saw a slight decline to 891.88 Cr in March 2025. The total operating income followed a similar pattern, reaching 895.30 Cr in March 2023 and then decreasing to 891.88 Cr in March 2025. The company's total expenditure, excluding depreciation, was 856.38 Cr in March 2025, up from 768.29 Cr in March 2024. Operating profit (PBDIT) increased to 43.56 Cr in March 2025 from 34.26 Cr in March 2024, indicating improved operational efficiency. Profit before tax also rose to 24.18 Cr in March 2025, compared to 13.84 Cr in March 2024, while profit after tax was 17.11 Cr in March 2025, slightly down from 17.82 Cr in March 2023. The company's total assets were 721.69 Cr in March 2025, with total liabilities at 721.69 Cr, reflecting a stable financial position. Cash flow from operating activities improved to 33.00 Cr in March 2025, up from 24.00 Cr in March 2024, contributing to a net cash inflow of 1.00 Cr in March 2025. Overall, Sicagen India has shown resilience with a gradual recovery in profits and cash flow despite fluctuations in sales.

Are Sicagen India Ltd latest results good or bad?

Sicagen India Ltd's latest results show a 14.69% revenue growth year-on-year, but profitability concerns persist with unchanged net profit and declining margins. Overall, the results are considered unfavorable, leading to a "SELL" rating due to ongoing operational challenges.

Sicagen India Ltd's latest results present a mixed picture, indicating ongoing challenges despite some positive developments. In the most recent quarter, the company reported a revenue growth of 14.69% year-on-year, reaching ₹226.76 crores. This growth reflects the company's ability to expand its market presence across various segments. However, profitability remains a significant concern, as net profit for the quarter was ₹4.14 crores, unchanged from the previous year, and down 8.81% from the previous quarter.<BR><BR>Operating margins have also contracted, falling to 4.00% from 4.18% year-on-year, and the profit after tax (PAT) margin decreased to 1.83% from 2.09%. These figures highlight the company's struggles with operational efficiency and cost management, which are critical for improving profitability.<BR><BR>Additionally, the company's return on equity (ROE) stands at a low 2.45%, raising concerns about capital efficiency. Given these factors, Sicagen India currently carries a "SELL" rating, as the structural challenges it faces appear to outweigh its attractive valuation metrics. Overall, while there are signs of revenue growth, the lack of corresponding profit expansion and declining margins suggest that the latest results are not favorable.

Should I buy, sell or hold Sicagen India Ltd?

Which are the latest news on Sicagen India?

When is the next results date for Sicagen India Ltd?

The next results date for Sicagen India Ltd is 13 May 2026.

The next results date for Sicagen India Ltd is scheduled for 13 May 2026.

Why is Sicagen India Ltd falling/rising?

As of 08-May, Sicagen India Ltd's stock price is Rs 54.84, down 3.06% today after a trend reversal. Despite a year-to-date decline of 9.79%, the stock has outperformed the Sensex over the past three years, indicating volatility but also increased investor interest.

As of 08-May, Sicagen India Ltd's stock price is currently at Rs 54.84, reflecting a decrease of Rs 1.73 or 3.06%. The stock has underperformed its sector by 2.92% today and has experienced a trend reversal, falling after two consecutive days of gains. Although the stock opened with a gain of 2.53% today and reached an intraday high of Rs 58.7, it also touched a low of Rs 53.77, indicating significant volatility with an intraday fluctuation of 5.22%.<BR><BR>In terms of performance over different periods, the stock has shown a year-to-date decline of 9.79%, which is slightly worse than the Sensex's decline of 9.26%. However, over the past three years, Sicagen India Ltd has outperformed the Sensex with a return of 48.78% compared to the benchmark's 25.20%. The stock's liquidity appears adequate for trading, with a notable increase in delivery volume of 31.27k on 07 May, which is up by 255.69% against the five-day average.<BR><BR>Overall, the current decline in the stock price can be attributed to its recent trend reversal and high volatility, despite some positive indicators such as increased investor participation and historical outperformance over longer periods.